Aperam (OTCMKTS:APEMY – Get Free Report) announced its earnings results on Friday. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.41 by ($0.31), Zacks reports. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. Aperam had a return on equity of 2.34% and a net margin of 2.10%.
Aperam Stock Down 2.3%
APEMY opened at $36.89 on Friday. The business has a 50 day moving average of $47.28 and a 200-day moving average of $49.62. The stock has a market capitalization of $2.70 billion, a price-to-earnings ratio of 15.06 and a beta of 1.40. The company has a current ratio of 1.63, a quick ratio of 0.55 and a debt-to-equity ratio of 0.34. Aperam has a 1-year low of $35.30 and a 1-year high of $61.65.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on APEMY shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Aperam in a report on Friday, September 4th. Zacks Research lowered Aperam from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 12th. Three equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold”.
Get Our Latest Analysis on APEMY
About Aperam
Aperam SA is a Luxembourg-based producer of stainless and specialty steel products. The company manufactures a broad range of stainless steel, electrical steel and specialty alloys for applications in industries such as automotive, construction, engineering, energy, food processing and consumer goods.
Its product portfolio includes flat and long stainless steel products, precision and specialty materials, and high-performance alloys designed for demanding industrial uses. Aperam also provides processing, distribution and technical services through its services and solutions activities.
The company has an integrated industrial and commercial presence across Europe and Brazil, with additional international sales coverage.
Further Reading
- Five stocks we like better than Aperam
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
Receive News & Ratings for Aperam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aperam and related companies with MarketBeat.com's FREE daily email newsletter.
